PolyPeptide Group
Tracked across 3 events · 34 articles · First seen Jul 19, 2026 · Last active Aug 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Target; shareholders receive a 40% premium; company to become a wholly owned subsidiary and delisted.
Jul 19, 2026 · 22 articles
Business
Impact: PolyPeptide Group is the target of Samsung Biologics — Samsung Biologics America' planned acquisition, which will broaden Samsung's portfolio into peptide-based therapeutics. The acquisition is expected to be funded by the rights offering proceeds.
Jul 20, 2026 · 6 articles
Business
Impact: PolyPeptide Group was acquired by Samsung Electronics, highlighting demand for peptide manufacturing capacity. This is referenced as a market validation.
Jul 24, 2026 · 6 articles
ERGEN INTELLIGENCE
Track PolyPeptide Group live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard